Annexon Inc. (ANNX)
NASDAQ: ANNX
· Real-Time Price · USD
2.34
-0.10 (-4.29%)
At close: Aug 18, 2025, 3:59 PM
2.36
0.85%
After-hours: Aug 18, 2025, 07:55 PM EDT
-4.29% (1D)
| Bid | 2.32 |
| Market Cap | 256.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -167.38M |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -1.81 |
| Forward PE | -1.62 |
| Analyst | Buy |
| Ask | 2.57 |
| Volume | 1,483,634 |
| Avg. Volume (20D) | 1,489,893 |
| Open | 2.48 |
| Previous Close | 2.44 |
| Day's Range | 2.34 - 2.57 |
| 52-Week Range | 1.28 - 7.85 |
| Beta | 1.30 |
About ANNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-5.52%
Annexon shares are trading higher after the compan...
Unlock content with
Pro Subscription
8 months ago
+13.96%
Annexon shares are trading higher after the company announced topline results from a study supporting Anx005 as a potential treatment for Guillain-barré syndrome.
